Brief: Parnell Pharmaceuticals announces pricing of underwritten public offering
12/05/2016 12:00
May 12 (Reuters) - Parnell Pharmaceuticals Holdings Ltd
PARN.O :
* Says offering of 2.55 million common shares priced for
$4.2 million
* Parnell Pharmaceuticals Holdings Ltd announces pricing of
an underwritten public offering of common stock
Source text for Eikon: ID:nGNXMRKNWa
Further company coverage: PARN.O
(Bengaluru Newsroom: +1-646-223-8780)
Recent news on Parnell Pharmaceuticals Holdings
See all newsBrief: Parnell Pharmaceuticals announces intention to move from Nasdaq OMX global market
Brief: Parnell Pharmaceuticals sees FY 2016 revenue of $14 million to $16 million
Brief: Parnell Pharmaceuticals says manufacturing deal with Merial
Brief: Parnell Pharmaceuticals announces pricing of underwritten public offering
Brief: Parnell Pharmaceuticals Q1 revenue rose 43 percent to $2.2 mln